Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
7
×
deals
7
×
life sciences
national blog main
san francisco blog main
san francisco top stories
national top stories
new york blog main
new york top stories
biotech
eli lilly
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
investing
medicare
roboticsai
vaccines
abbvie
aduro biotech
What
companies
7
×
bio
drug
new
roundup
ago
deal
hasn’t
latest
life
medicines
nash
news
pharmaceutical
price
rna
abandoning
admits
alzheimer’s
approval
approved
arrival
baggage
bets
big
biogen’s
biopharmaceutical
biotech
biotechs
cancer
classes
combinator
comes
convo
cut
cuts
date
days
development
dicerna
Language
unset
Current search:
deals
×
companies
×
" boston top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines